Inhibition of concanavalin A-induced mice hepatitis by coumarin derivatives

被引:46
|
作者
Okamoto, T
Yoshida, S
Kobayashi, T
Okabe, S
机构
[1] Nippon Chemiphar Co Ltd, Res Labs, Misato, Saitama 3410005, Japan
[2] Kyoto Pharmaceut Univ, Dept Appl Pharmacol, Kyoto 6078414, Japan
来源
JAPANESE JOURNAL OF PHARMACOLOGY | 2001年 / 85卷 / 01期
关键词
coumarin; concanavalin A; liver;
D O I
10.1254/jjp.85.95
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of coumarin derivatives, osthole, imperatorin, Pd-Ia, Pd-II and Pd-III, on mice concanavalin A (Con A) (0.2 mg/mouse, i.v.)-induced hepatitis were studied. At the dose of 200 mg/kg (i.p.), these coumarins inhibited more than 90% of the Con A-induced elevation of plasma alanine aminotransferase activity, but glycyrrhizin (200 mg/kg, i.p.) caused only 45% inhibition. At the dose of 100 mg/kg (i.p.), osthole produced the strongest inhibition among these coumarins. The inhibitory activity of osthole is lost when its 7-methoxy group is replaced by a 7-hydroxy group to form osthenol. The present results showed that coumarin derivatives inhibited Con A-induced hepatitis, with osthole being the most inhibitory.
引用
收藏
页码:95 / 97
页数:3
相关论文
共 50 条
  • [1] Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice
    Goto, Megumi
    Tanaka, Yoshitaka
    Murakawa, Masao
    Kadoshima-Yamaoka, Kumiko
    Inoue, Hidekazu
    Murafuji, Hidenobu
    Nagahira, Asako
    Kanki, Satomi
    Hayashi, Yasuhiro
    Nagahira, Kazuhiro
    Ogata, Atsuto
    Miura, Kenju
    Nakatsuka, Takashi
    Chamoto, Kenji
    Fukuda, Yoshiaki
    Nishimura, Takashi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (11) : 1347 - 1351
  • [2] Aminoguanidine prevents concanavalin A-induced hepatitis in mice
    Okamoto, T
    Masuda, Y
    Kawasaki, T
    Shinohara, M
    Matsuzaki, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (2-3) : 125 - 130
  • [3] Prevention of concanavalin A-induced mice hepatitis by molsidomine
    Okamoto, T
    Masuda, Y
    Kawasaki, T
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (03) : 307 - 309
  • [4] Development of anorexia in concanavalin A-induced hepatitis in mice
    Okamoto, T
    Okabe, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (02) : 169 - 172
  • [5] Dexmedetomidine premedication attenuates concanavalin A-induced hepatitis in mice
    Wang, Haibin
    Hu, Baoji
    Zou, Yun
    Bo, Lulong
    Wang, Jun
    Li, Jinbao
    Luo, Yan
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2014, 39 (05): : 755 - 764
  • [6] Protective effect of galangin in Concanavalin A-induced hepatitis in mice
    Luo, Qingqiong
    Zhu, Liping
    Ding, Jieying
    Zhuang, Xing
    Xu, Lili
    Chen, Fuxiang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2983 - 2992
  • [7] Role of CPG DNA in Concanavalin A-induced hepatitis in mice
    Abe, K
    Ohira, H
    Kobayashi, H
    Rai, T
    Yokokawa, J
    Takiguchi, J
    Shishido, S
    Sato, Y
    GASTROENTEROLOGY, 2003, 124 (04) : A786 - A786
  • [8] Paeoniflorin protects against concanavalin A-induced hepatitis in mice
    Chen, Mingsheng
    Cao, Lijun
    Luo, Yijun
    Feng, Xiaofeng
    Sun, Lu
    Wen, Min
    Peng, Shaobin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 24 (01) : 42 - 49
  • [9] Endogenous αCGRP protects against concanavalin A-induced hepatitis in mice
    Kainiyoshi, A
    Sakurai, T
    Ichikawa-Shindo, Y
    Fukuchi, J
    Kawate, H
    Muto, S
    Tagawa, Y
    Shindo, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (01) : 152 - 158
  • [10] CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice
    Zhang, Hui
    Gong, Quan
    Li, Jun-hua
    Kong, Xiao-ling
    Tian, Li
    Duan, Li-hua
    Tong, Jing
    Song, Fei-fei
    Fang, Min
    Zheng, Fang
    Xiong, Ping
    Tan, Zheng
    Gong, Fei-li
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (01) : 79 - 85